Click here for Somavert® (pegvisomant) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Somavert is used in the treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalise IGF-I concentrations or was not tolerated.
Patients who do not meet the criteria but are funded by an individual funding request (IFR) will continue to receive funding via that route and do not need inclusion into Blueteq
This animation explains how to set up a new user account on Blueteq and what information is needed.
To find out more about ACRODAT, supporting your patients or to order starter kits
Discover how Blueteq fits within the Somavert prescribing pathway and the different types of homecare we offer
1. NHS England 16050/P Clinical Commissioning Policy. December 2016. Available here (date accessed January 2022)
2. Somavert Summary of Product Characteristics. Great Britain available here. Northern Ireland available here
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
OK, We will need you to sign in before we can determine if you are aligned with a Pﬁzer promotional colleague.This is an interstitial message to prompt a HCP before they login.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?